Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
50,956,459
-
Share change
-
+823,061
-
Total reported value
-
$6,527,263,115
-
Put/Call ratio
-
75%
-
Price per share
-
$128.14
-
Number of holders
-
397
-
Value change
-
+$97,208,216
-
Number of buys
-
201
-
Number of sells
-
188
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2019
As of 30 Sep 2019,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,956,459 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, Nuveen Asset Management, LLC, FMR LLC, LSV ASSET MANAGEMENT, STATE STREET CORP, Boston Partners, and AQR CAPITAL MANAGEMENT LLC.
This page lists
398
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.